Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cardiac Arrest: A Rare Complication of Intrathecal Baclofen Withdrawal

View through CrossRef
Baclofen, a GABA agonist, is used for the management of spasticity. Intrathecal route is indicated in cases of severe spasticity associated with spinal cord injury. Baclofen withdrawal symptoms can happen after IT pump removal which can present as anxiety, paranoia, psychosis, seizures, hallucinations, severe spasticity and dyskinesia. Cardiac arrest after baclofen withdrawal is rare with only 2 cases in literature so far however in both cases IT-pump was replaced. We present a case of PEA arrest after baclofen IT-pump removal which was managed without replacing. 33 year-old male with history of paraplegia from cervical spinal cord injury (C-6) level, chronic spasticity, fibular osteomyelitis and chronic sacral ulcers presented with wound dehiscence and exposed baclofen pump which was replaced 4 weeks ago due to the end of the pump’s life. After 24–48 h of removal of the baclofen pump, cardiovascular instability in the form of supra ventricular tachycardia with hypotension and altered mentation was noted. It evolved to progressive clinical worsening with stiffness of body, loss of responsiveness, and up-rolling of eyes. Patient underwent PEA, and ROSC after 3 rounds of CPR. He was subsequently intubated, mechanically ventilated and sedated with midazolam intravenously. Baclofen and clonazepam were started through the feeding tube. Over a period of 10 days, midazolam was weaned, and baseline clinical stability was achieved without IT-baclofen pump. Though rare, cardiac arrest can happen after baclofen withdrawal. High index of clinical suspicion is advised for long term baclofen pump patients after pump explant to prevent withdrawal symptoms and complications.
Title: Cardiac Arrest: A Rare Complication of Intrathecal Baclofen Withdrawal
Description:
Baclofen, a GABA agonist, is used for the management of spasticity.
Intrathecal route is indicated in cases of severe spasticity associated with spinal cord injury.
Baclofen withdrawal symptoms can happen after IT pump removal which can present as anxiety, paranoia, psychosis, seizures, hallucinations, severe spasticity and dyskinesia.
Cardiac arrest after baclofen withdrawal is rare with only 2 cases in literature so far however in both cases IT-pump was replaced.
We present a case of PEA arrest after baclofen IT-pump removal which was managed without replacing.
33 year-old male with history of paraplegia from cervical spinal cord injury (C-6) level, chronic spasticity, fibular osteomyelitis and chronic sacral ulcers presented with wound dehiscence and exposed baclofen pump which was replaced 4 weeks ago due to the end of the pump’s life.
After 24–48 h of removal of the baclofen pump, cardiovascular instability in the form of supra ventricular tachycardia with hypotension and altered mentation was noted.
It evolved to progressive clinical worsening with stiffness of body, loss of responsiveness, and up-rolling of eyes.
Patient underwent PEA, and ROSC after 3 rounds of CPR.
He was subsequently intubated, mechanically ventilated and sedated with midazolam intravenously.
Baclofen and clonazepam were started through the feeding tube.
Over a period of 10 days, midazolam was weaned, and baseline clinical stability was achieved without IT-baclofen pump.
Though rare, cardiac arrest can happen after baclofen withdrawal.
High index of clinical suspicion is advised for long term baclofen pump patients after pump explant to prevent withdrawal symptoms and complications.

Related Results

0864 Severe Central Sleep Apnea
0864 Severe Central Sleep Apnea
Abstract Introduction Central sleep apnea (CSA) is a rare form of sleep disordered breathing with repeated apneic episodes with ...
Prepontine placement of an intrathecal baclofen pump catheter for treatment of dystonia
Prepontine placement of an intrathecal baclofen pump catheter for treatment of dystonia
Background: Cerebral palsy with medically refractory spasticity and dystonia is a condition that often benefits from intrathecal baclofen pump therapy to treat these symptoms. In ...
Intrathecal Baclofen for Management of Spastic Cerebral Palsy: Multicenter Trial
Intrathecal Baclofen for Management of Spastic Cerebral Palsy: Multicenter Trial
Intrathecal baclofen infusion has demonstrated effectiveness in decreasing spasticity of spinal origin. Oral antispasticity medication is minimally effective or not well tolerated ...
Baclofen and phaclofen modulate GABA release from slices of rat cerebral cortex and spinal cord but not from retina
Baclofen and phaclofen modulate GABA release from slices of rat cerebral cortex and spinal cord but not from retina
The effects of (−)‐baclofen, muscimol and phaclofen on endogeneous γ‐aminobutyric acid (GABA) release from rat cortical slices, spinal cord slices and entire retinas were studied.T...
Altered Mental Status at High Altitude
Altered Mental Status at High Altitude
Intrathecal baclofen pumps are commonly used in pediatric patients with spastic cerebral palsy. Baclofen binds to γ-aminobutyric acid receptors to inhibit both monosynaptic and pol...
Awareness about Intrathecal Drug Administration among Dental students
Awareness about Intrathecal Drug Administration among Dental students
Intrathecal administration includes the immediate infusion of the medication in Cerebro Spinal Fluid(CSF) internal to the intrathecal space of the spinal column. The intrathecal co...
A standardized protocol to reduce pediatric baclofen pump infections: a quality improvement initiative
A standardized protocol to reduce pediatric baclofen pump infections: a quality improvement initiative
OBJECTIVEIntrathecal baclofen pumps are generally placed in children for the treatment of spasticity and dystonia. Use of implants in this pediatric population with comorbidities i...

Back to Top